Inspira Technologies (IINN) - Market Cap to Net Assets Ratio

inspira-technologies.com - graphic logo of issuer IINN

The innovative brand Inspira Technologies Oxy (IINN) creates secure respiratory support systems, whose breakthrough developments in non-intubated extracorporeal oxygenation are transforming intensive care medicine, which is reflected in the price chart of the asset with the 6.36 indicator. Business stability is based on the Israeli center, where alternatives to mechanical ventilation are developed to saturate blood with oxygen using non-invasive methods.

inspira-technologies.com (IINN) - Market Value to Book Value from 07/04/2022 to 05/20/2026
Manufactured product of Inspira Technologies Oxy

This indicator compares the market value of the business with its book value of equity. For Inspira Technologies Oxy (IINN), this metric reflects the market premium over the value of assets developed for the creation of energy-efficient blood oxygenation systems. By analyzing the ratio of the company's market capitalization to its book capitalization, an investor can identify valuation consolidation phases. Values above one indicate growth expectations priced in. This allows for the determination of the premium paid for innovative ESG solutions in medicine.

Competing companies

DexCom, Inc. (DXCM) - Market Value to Book Value Ratio|Capitalization to Book Value Ratio PEN|Market Cap to Net Assets Ratio NOVT|HAE (Haemonetics Corp) - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio INSP|PRCT (Procept) - Market Value to Book Value|Market Capitalization to Book Value Ratio CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Market-to-Book Ratio|INMD - Market Value to Book Value Ratio|Market Value to Book Value PMI (Picard Medical Corp)|SRDX: Market Capitalization to Book Value Ratio|Senseonics Holdings, Inc. (SENS) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc.|Tactile Systems Technology Inc. - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio SNWV|OM - Market-to-Book Ratio|Electromed - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio LENSAR Inc LNSR|RCEL: Market Cap to Net Assets Ratio|Profound Medical Corp. - Market Cap to Book Value Multiple|BDMD: Market Capitalization to Book Value Ratio|EDAP - Market Capitalization to Book Value|APYX (Apyx Medical Corp) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Market Cap to Net Assets Ratio LUNG (Pulmonx Corporation)|TELA (telabio.com) - Market Value to Book Value|Market Value to Book Value Ratio CytoSorbents Corporation CTSO|SRTS - Market Cap to Net Assets Ratio|Zynex Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio electroCore, Inc.|RBOT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ICU|IRIX (IRIDEX Corp) - Market Capitalization to Book Value Ratio|Intelligent Bio (INBS) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio XAIR|Market Cap to Net Assets Ratio Profusa, Inc PFSA|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|Market Capitalization to Book Value Ratio GlucoTrack Inc. GCTK|NAOV - Market Value to Book Value Ratio|VERO: Market Value to Book Value Ratio|NUWE (CHF Solutions) - Market Cap to Net Assets Ratio|Aethlon Medical Corp - Market Value to Book Value|ASXC (Asensus Surgical Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio avinger.com AVGR|Market Value to Book Value Ratio biosig.com (BSGM)|Cutera Inc. (CUTR) - Market Value to Equity Ratio|Know Labs Corp - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Nevro Corp. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Market Value to Book Value Ratio